Common Contracts
3 similar First Supplemental Indenture contracts by Cv Therapeutics Inc
ContractFirst Supplemental Indenture • May 12th, 2009 • Cv Therapeutics Inc • Biological products, (no disgnostic substances) • New York
This FIRST SUPPLEMENTAL INDENTURE, dated as of May 11, 2009 (this “First Supplemental Indenture”), is made by and among GILEAD PALO ALTO, INC. (formerly known as CV Therapeutics Inc.), a Delaware corporation (the “Company”) and U.S. BANK NATIONAL ASSOCIATION, as Trustee (the “Trustee”), under the Indenture referred to herein. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the Indenture referred to below.
ContractFirst Supplemental Indenture • May 12th, 2009 • Cv Therapeutics Inc • Biological products, (no disgnostic substances) • New York
This FIRST SUPPLEMENTAL INDENTURE, dated as of May 11, 2009 (this “First Supplemental Indenture”), is made by and among GILEAD PALO ALTO, INC. (formerly known as CV Therapeutics Inc.), a Delaware corporation (the “Company”) and U.S. BANK NATIONAL ASSOCIATION, as Trustee (the “Trustee”), under the Indenture referred to herein. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the Indenture referred to below.
ContractFirst Supplemental Indenture • May 12th, 2009 • Cv Therapeutics Inc • Biological products, (no disgnostic substances) • New York
This FIRST SUPPLEMENTAL INDENTURE, dated as of May 11, 2009 (this “First Supplemental Indenture”), is made by and among GILEAD PALO ALTO, INC. (formerly known as CV Therapeutics Inc.), a Delaware corporation (the “Company”) and U.S. BANK NATIONAL ASSOCIATION, as Trustee (the “Trustee”), under the Indenture referred to herein. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the Indenture referred to below.
